Details for New Drug Application (NDA): 209933
✉ Email this page to a colleague
The generic ingredient in NEOSTIGMINE METHYLSULFATE is neostigmine methylsulfate. There are nine drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the neostigmine methylsulfate profile page.
Summary for 209933
Tradename: | NEOSTIGMINE METHYLSULFATE |
Applicant: | Amphastar Pharms Inc |
Ingredient: | neostigmine methylsulfate |
Patents: | 0 |
Pharmacology for NDA: 209933
Mechanism of Action | Cholinesterase Inhibitors |
Medical Subject Heading (MeSH) Categories for 209933
Suppliers and Packaging for NDA: 209933
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 209933 | ANDA | Henry Schein, Inc. | 0404-9925 | 0404-9925-10 | 1 VIAL, MULTI-DOSE in 1 BAG (0404-9925-10) / 10 mL in 1 VIAL, MULTI-DOSE |
NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 209933 | ANDA | Amphastar Pharmaceuticals, Inc. | 0548-9601 | 0548-9601-00 | 10 CARTON in 1 PACKAGE (0548-9601-00) / 1 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 5MG/10ML (0.5MG/ML) | ||||
Approval Date: | Sep 25, 2017 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 10MG/10ML (1MG/ML) | ||||
Approval Date: | Sep 25, 2017 | TE: | AP | RLD: | No |
Complete Access Available with Subscription